← Scroll for more →
Cardiol Therapeutics Inc. (CRDL)
Biological Products, (No Diagnostic Substances)
Latest Price
$1.11
TTM P/E
--
Normalized P/E
--
TTM Div Yield
--
Fwd Div Yield
--
Book Value
--
P/B Ratio
--
Institutional Ownership
33.9% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| MMCAP International Inc. SPC | 15.60M | $16.0M | 17.93% | +246.2K | 2026-06-30 |
| Tejara Capital Ltd | 5.11M | $5.0M | 5.88% | -16.3K | 2026-06-30 |
| Ikarian Capital, LLC | 3.33M | $3.0M | 3.82% | +600.0K | 2026-06-30 |
| Boothbay Fund Management, LLC | 975.7K | $1.0M | 1.12% | +180.8K | 2026-06-30 |
| Citadel Advisors LLC | 829.3K | -- | 0.95% | -67.2K | 2026-06-30 |
| Renaissance Technologies LLC | 772.8K | -- | 0.89% | +543.0K | 2026-06-30 |
| Two Sigma Investments, LP | 746.9K | -- | 0.86% | -- | 2026-06-30 |
| Integrity Alliance, LLC. | 388.5K | -- | 0.45% | -76.5K | 2026-06-30 |
| Morgan Stanley | 355.0K | -- | 0.41% | +104.6K | 2026-06-30 |
| Goldman Sachs Group Inc | 333.9K | -- | 0.38% | +1.5K | 2026-06-30 |